You are here

Home › Pfizer and Clear Creek Bio partner to develop oral COVID-19 drug › Pfizer and Clear Creek Bio partner to develop oral COVID-19 drug

Pfizer and Clear Creek Bio partner to develop oral COVID-19 drug

Primary tabs

Pfizer and Clear Creek Bio partner to develop oral COVID-19 drug

Tue, 2022-12-06 11:09 — mike kraft
Pfizer partners with Clear Creek Bio to develop oral COVID-19 drug Pfizer Inc and Clear Creek Bio Inc on Tuesday announced a collaboration to identify a potential drug candidate and develop a new class of oral treatment against COVID-19, as Pfizer seeks to expand its anti-infective pipeline. Reuters Reuters

...

Pfizer already has a COVID antiviral pill Paxlovid, which the drugmaker expects to generate about $22 billion in revenue this year.

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Treatments
Disease
Disease Prevention
Government
Research
Science
Problem, Solution, SitRep, or ?: 
Situation Report
Groups this Group Post belongs to: 
Global Health
Medical - global
- Private group -
Workflow history
Revision ID Field name Date Old state New state name By Comment Operations
No state No state
howdy folks
Page loaded in 0.490 seconds.